Evidence map›Paper›PMID 37603350›Full record

ArticleBlood advances2023

Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study.

Bhavana Bhatnagar, Jessica Kohlschmidt, Shelley J Orwick, Daelynn R Buelow, Sydney Fobare, Christopher C Oakes, Jonathan E Kolitz, Geoff Uy, Wendy Stock, Bayard L Powell and 7 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 1 country.

Bhavana BhatnagarDepartment of Hematology and Medical Oncology, West Virginia University Cancer Institute, Wheeling Hospital, Wheeling, WV.ORCID 0000-0002-4869-0712
Jessica KohlschmidtAlliance Statistics and Data Management Center, The Ohio State University, Columbus, OH.
Shelley J OrwickDivision of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH.ORCID 0000-0002-4537-1409
Daelynn R BuelowDivision of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH.
Sydney FobareDepartment of Internal Medicine, Medical Student Training Program, College of Medicine, The Ohio State University, Columbus, OH.
Christopher C OakesClara D. Bloomfield Center, The Ohio State Comprehensive Cancer Center, Columbus, OH.
Jonathan E KolitzDivision of Oncology, Northwell Health, Lake Success, NY.
Geoff UyDivision of Oncology, Department of Medicine, Washington University, St. Louis, MO.ORCID 0000-0002-7809-0996
Wendy StockDivision of Hematology-Oncology, Department of Internal Medicine, University of Chicago, Chicago, IL.
Bayard L PowellDivision of Hematology-Oncology, Department of Internal Medicine, Wake Forest University Health System, Winston-Salem, NC.
Deedra NicoletAlliance Statistics and Data Management Center, The Ohio State University, Columbus, OH.ORCID 0000-0001-7796-0251
Erin K HertleinDivision of Hematology-Oncology, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH.ORCID 0000-0001-8493-5679
Krzysztof MrózekClara D. Bloomfield Center, The Ohio State Comprehensive Cancer Center, Columbus, OH.
James S BlachlyDivision of Hematology, Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH.ORCID 0000-0002-4275-5562
Ann-Kathrin EisfeldClara D. Bloomfield Center, The Ohio State Comprehensive Cancer Center, Columbus, OH.
Sharyn D BakerDivision of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH.
John C ByrdDivision of Hematology-Oncology, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH.
The Ohio State University · USSylvester Comprehensive Cancer Center · USUniversity of Cincinnati Medical Center · USNorthwell Health · USUniversity Health System · USUniversity of Chicago · USWashington University in St. Louis · USWheeling Hospital · US

Funding

Member Site CoreU10CA180821 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI Evanthia Galanis · 2014 to 2026
$177.3M
Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
Statistics CoreU10CA180882 · NCI · MAYO CLINIC ROCHESTER · PI Sumithra Jay Mandrekar · 2014 to 2026
$115.0M
Wake Forest NCORP Research BaseUG1CA189824 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Emily Van Meter Dressler, GLENN J LESSER · 2014 to 2026
$57.9M
THE ALLIANCE NCTN BIOREPOSITORY AND BIOSPECIMEN RESOURCEU24CA196171 · NCI · WASHINGTON UNIVERSITY · PI Mine Cicek, Wendy Frankel · 2015 to 2026
$35.0M
Northwell Health NCORPUG1CA189850 · NCI · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI VINCENT P VINCIGUERRA · 2014 to 2026
$13.3M
WASHINGTON UNIVERSITY / SITEMAN CANCER CENTER LEAD ACADEMIC SITEUG1CA233339 · NCI · WASHINGTON UNIVERSITY · PI NANCY L BARTLETT, Clifford Grant Robinson · 2019 to 2026
$11.3M
OSU as a Network Lead Academic Participating Site for the NCI NCTNUG1CA233331 · NCI · OHIO STATE UNIVERSITY · PI John L. Hays, Dwight H. Owen · 2019 to 2026
$8.9M
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer CareUG1CA233180 · NCI · DANA-FARBER CANCER INST · PI Harold John Burstein · 2019 to 2026
$8.6M
Targeted Therapy for LeukemiaR35CA197734 · NCI · UNIVERSITY OF CINCINNATI · PI BYRD, JOHN C. · 2015 to 2021
$6.6M
ITSC for Leukemia: Novel Molecular strategies for NCTN "Individualized" TherapiesUG1CA233338 · NCI · UNIVERSITY OF CINCINNATI · PI BYRD, JOHN C. · 2019 to 2025
$4.5M
UG1 - NCTN (Network Lead)UG1CA233327 · NCI · UNIVERSITY OF CHICAGO · PI STEVEN J CHMURA, HEDY L KINDLER · 2019 to 2026
$4.4M
NCI NIH HHS P30 CA016058NCI NIH HHS R35 CA197734NCI NIH HHS U10 CA180821NCI NIH HHS U10 CA180882NCI NIH HHS U24 CA196171NCI NIH HHS UG1 CA189850NCI NIH HHS UG1 CA233180NCI NIH HHS UG1 CA233327NCI NIH HHS UG1 CA233331NCI NIH HHS UG1 CA233338NCI NIH HHS UG1 CA233339
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Myeloid, AcuteAdultHumansMutationWT1 ProteinsWT1 protein, humanWT1 Proteins

Identifiers

PMID37603350
PMCPMC10448419
OpenAlexW4379879030

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.